BPTH Recent News

Global RNAi Drug Delivery Market 2014-2018: Read What's Trending M2 - Wed Feb 19, 12:15PM CST
Latest Thyroid Cancer Pipeline Review M2 - Tue Jan 28, 10:20AM CST
Bio-Path Holdings Inc expects USD10m in registered direct offering M2 - Fri Jan 17, 10:38AM CST
Bio-Path Holdings, Inc. to Raise $10 Million in Registered Direct Offering Business Wire - Thu Jan 16, 7:00AM CST
Bio-Path Holdings to Present at the Biotech Showcase(TM) 2014 Conference Business Wire - Mon Jan 06, 9:59AM CST
Preliminary Results from Bio-Path Holdings' Phase I Clinical Trial Presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans Business Wire - Mon Dec 09, 10:20AM CST
Bio-Path Holdings Reports Third Quarter 2013 Operational and Financial Results Business Wire - Fri Nov 15, 12:30PM CST
Data from Bio-Path Holdings Phase I Clinical Trial in Hematological Cancers to be Presented at American Society of Hematology Annual Meeting Business Wire - Thu Nov 07, 3:03PM CST
Bio-Path Holdings Inc retains Maxim Group LLC as investment banking firm M2 - Fri Sep 20, 8:00AM CDT
Bio-Path Holdings, Inc. Retains Investment Banking Firm Maxim Group LLC Business Wire - Thu Sep 19, 8:30AM CDT